Peginterferon A-2B plus ribavirin in relapser and mon-responder Brazilian HCV patients (2004)
Source: Liver International. Conference titles: Bienal Scientific Meeting of the International Association for the Study of the Liver. Unidade: FM
Subjects: INTERFERONS, ESTUDOS PROSPECTIVOS, GENÓTIPOS, HEPATITE C (VIROLOGIA), ANTIBIÓTICOS (USO TERAPÊUTICO), RESUMOS (EVENTOS)
ABNT
COELHO, H. S. M. et al. Peginterferon A-2B plus ribavirin in relapser and mon-responder Brazilian HCV patients. Liver International. Copenhagen: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2004APA
Coelho, H. S. M., Paixão, J., Gonçales Jr., F. L., Gonçales, N., Gonzales, A., Rosa, H., et al. (2004). Peginterferon A-2B plus ribavirin in relapser and mon-responder Brazilian HCV patients. Liver International. Copenhagen: Faculdade de Medicina, Universidade de São Paulo.NLM
Coelho HSM, Paixão J, Gonçales Jr. FL, Gonçales N, Gonzales A, Rosa H, Borges A, Barone AA, Focaccia R, Oliveira U, Ferraz ML, Perez R, Lobato C, Weirich J, Vila R, Giannella ML. Peginterferon A-2B plus ribavirin in relapser and mon-responder Brazilian HCV patients. Liver International. 2004 ; 24 64.[citado 2024 nov. 14 ]Vancouver
Coelho HSM, Paixão J, Gonçales Jr. FL, Gonçales N, Gonzales A, Rosa H, Borges A, Barone AA, Focaccia R, Oliveira U, Ferraz ML, Perez R, Lobato C, Weirich J, Vila R, Giannella ML. Peginterferon A-2B plus ribavirin in relapser and mon-responder Brazilian HCV patients. Liver International. 2004 ; 24 64.[citado 2024 nov. 14 ]